Flinton Capital Management LLC boosted its position in AmerisourceBergen (NYSE:ABC) by 2.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 57,834 shares of the company’s stock after buying an additional 1,224 shares during the quarter. Flinton Capital Management LLC’s holdings in AmerisourceBergen were worth $5,310,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Benjamin F. Edwards & Company Inc. grew its position in AmerisourceBergen by 9.8% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 5,580 shares of the company’s stock worth $512,000 after purchasing an additional 500 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in AmerisourceBergen by 8.8% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 6,298 shares of the company’s stock worth $579,000 after purchasing an additional 507 shares during the last quarter. Bray Capital Advisors grew its position in AmerisourceBergen by 2.5% in the 4th quarter. Bray Capital Advisors now owns 21,890 shares of the company’s stock worth $2,010,000 after purchasing an additional 525 shares during the last quarter. Meadow Creek Investment Management LLC grew its position in AmerisourceBergen by 2.2% in the 4th quarter. Meadow Creek Investment Management LLC now owns 27,216 shares of the company’s stock worth $2,499,000 after purchasing an additional 576 shares during the last quarter. Finally, Ridgewood Investments LLC grew its position in AmerisourceBergen by 16.7% in the 4th quarter. Ridgewood Investments LLC now owns 4,093 shares of the company’s stock worth $376,000 after purchasing an additional 586 shares during the last quarter. Institutional investors own 67.31% of the company’s stock.
In other AmerisourceBergen news, Director Richard W. Gochnauer sold 2,000 shares of the business’s stock in a transaction dated Wednesday, January 10th. The shares were sold at an average price of $96.54, for a total value of $193,080.00. Following the completion of the transaction, the director now directly owns 12,947 shares of the company’s stock, valued at $1,249,903.38. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Peyton R. Howell sold 3,000 shares of the business’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $95.11, for a total transaction of $285,330.00. Following the completion of the transaction, the insider now directly owns 49,189 shares of the company’s stock, valued at $4,678,365.79. The disclosure for this sale can be found here. Insiders have sold a total of 159,809 shares of company stock valued at $14,924,442 over the last three months. 27.30% of the stock is currently owned by insiders.
Several analysts have issued reports on ABC shares. Cowen set a $107.00 price target on shares of AmerisourceBergen and gave the stock a “buy” rating in a research report on Tuesday, December 12th. Goldman Sachs upgraded shares of AmerisourceBergen from a “neutral” rating to a “buy” rating in a research report on Friday, December 15th. Leerink Swann set a $105.00 target price on shares of AmerisourceBergen and gave the company a “buy” rating in a research report on Tuesday, January 2nd. Zacks Investment Research upgraded shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $105.00 target price on the stock in a research report on Wednesday, January 3rd. Finally, Evercore ISI assumed coverage on shares of AmerisourceBergen in a research report on Thursday, January 4th. They set an “outperform” rating and a $105.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. AmerisourceBergen has an average rating of “Buy” and a consensus price target of $102.72.
Shares of ABC stock opened at $85.41 on Friday. AmerisourceBergen has a 12-month low of $71.90 and a 12-month high of $106.27. The stock has a market cap of $18,946.45, a P/E ratio of 14.53, a PEG ratio of 1.29 and a beta of 1.06. The company has a quick ratio of 0.50, a current ratio of 0.95 and a debt-to-equity ratio of 1.61.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The firm had revenue of $40.47 billion during the quarter, compared to the consensus estimate of $40.42 billion. During the same period last year, the firm posted $1.36 EPS. The firm’s quarterly revenue was up 6.0% on a year-over-year basis. equities research analysts expect that AmerisourceBergen will post 6.58 EPS for the current fiscal year.
WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/07/amerisourcebergen-corp-abc-stake-boosted-by-flinton-capital-management-llc.html.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.